5-hydroxymethylcytosine (5-hmC) is an epigenetic modification (methylated cytosine) that is thought to be a derivative of 5-methylcytosine (5-mC). T4 β-glucosyltransferase catalyzes the transfer of glucose from uridine diphosphoglucose (UDP-Glucose) to the hydroxymethyl group 5-hmC, but does not modify 5-mC. This modifying enzyme can be used to differentiate these types of cytosine methylation. Specifically, after T4 β-glucosyltransferase treatment, restriction enzyme (e.g., MspI/HpaII) digestion or immunodetection can be used identify β-glucosyl-5-hydroxymethylcytosine (β-glu-5hmC) at particular loci, or genome-wide analyses can be accomplished by selective pull-down of β-glu-5hmC.
美国Clontech公司是一家专门致力于基因工程及蛋白质工程领域研究用产品的研发和生产的专业公司。公司产品涉及PCR产品、RT-PCR产品、cDNA文库构建、基因克隆、基因表达、基因分析、蛋白质技术等诸多领域。产品种类多达2000多种。Clontech公司拥有多种独立知识产权产品,其强大的科研实力和完善的质量管理体系(ISO9001)为Clontech产品的良好品质提供了可靠保障。